Clincosm LogoSign in Get a demo

thyroid cancer

Showing 1 - 25 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

Recruiting
  • Thyroid Cancer
  • Traditional neck dissection approach
  • Anterior neck dissection approach
  • Medellin, Antioquia, Colombia
    Hospital Alma Mater de Antioquia
Nov 20, 2023

Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

Not yet recruiting
  • Thyroid Cancer
  • 20 mg Famitinib & 1200 mg Adebrelimab
  • (no location specified)
Nov 26, 2023

Differentiated Thyroid Cancer Patients Treated With Different

Not yet recruiting
  • Thyroid Cancer
  • (no location specified)
Nov 15, 2023

Thyroid Cancer, Lymph Node Trial in Leon (US-guided fine needle aspiration (FNA))

Completed
  • Thyroid Cancer
  • Lymph Node
  • US-guided fine needle aspiration (FNA)
  • Leon, Guanajuato, Mexico
    Unidad Medica de Alta Especialidad No. 1, Bajío
Nov 6, 2023

Thyroid Cancer Trial (Pectoral nerve block)

Not yet recruiting
  • Thyroid Cancer
  • Pectoral nerve block
  • (no location specified)
Oct 25, 2023

Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)

Recruiting
  • Thyroid Cancer
  • +2 more
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Science
Oct 13, 2023

Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)

Recruiting
  • Thyroid Cancer
  • Recurrence
  • prophylactic central neck dissection
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Science
Oct 8, 2023

Thyroid Cancer Trial in Ann Arbor (Usual Care, CQUPLE)

Recruiting
  • Thyroid Cancer
  • Usual Care
  • CQUPLE
  • Ann Arbor, Michigan
    The University of Michigan Cancer Center
Oct 3, 2023

Thyroid Cancer Trial in Seoul (Three-dimensional patient-specific bioprinting trachea implantation)

Active, not recruiting
  • Thyroid Cancer
  • Three-dimensional patient-specific bioprinting trachea implantation
  • Seoul, Korea, Republic of
    Seoul St. Mary's Hospital
Sep 20, 2023

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Quality of Life in Differentiated Thyroid Carcinoma Undergoing

Not yet recruiting
  • Thyroid Cancer
  • minimally invasive procedure
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hopsital
Sep 13, 2023

Thyroid Cancer Trial in United States (Avutometinib, Defactinib)

Recruiting
  • Thyroid Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 17, 2023

Nasolacrimal Duct Obstruction, Thyroid Cancer Trial (Artificial Tears Methylcellulose)

Not yet recruiting
  • Nasolacrimal Duct Obstruction
  • Thyroid Cancer
  • Artificial Tears Methylcellulose
  • (no location specified)
Aug 17, 2023

Cross-sectional Case and Control Study on Quality of Life,

Recruiting
  • Papillary Thyroid Carcinoma
  • Thyroid Cancer
  • Thyroid lobectomy via trans-axillary approach
  • Thyroid lobectomy via open approach
  • Beijing, Beijing, China
    Department of General Surgery, Peking Union Medical College Hosp
Jul 5, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

Recruiting
  • Solid Tumor, Adult
  • +19 more
  • Irving, Texas
  • +2 more
May 24, 2023

Thyroidectomy, Goiter, Thyroid Cancer Trial in Taipei (Oxidized regenerated cellulose(ORC), Hyaluronic acid(HA))

Recruiting
  • Thyroidectomy
  • +2 more
  • Oxidized regenerated cellulose(ORC)
  • Hyaluronic acid(HA)
  • Taipei, Taiwan
    National Taiwan University Hospital
May 1, 2023

Disease Burden, Genetic Heterogeneity and Tumour Evolution in

Recruiting
  • Thyroid Cancer
  • Sample collection only
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Apr 28, 2023

HRQOL in Locally Advanced Thyroid Carcinoma

Recruiting
  • Thyroid Cancer
  • +2 more
  • Tyrosine kinase inhibitor drugs.
  • Fuzhou, Fujian, China
    Road Fuma No.420
Apr 11, 2023

Surgical Management of Advanced Thyroid Cancer

Recruiting
  • Thyroid Carcinoma
  • +6 more
  • Thyroidectomy with or without lymphadenectomy or multivisceral resection
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 31, 2023

Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

Recruiting
  • Thyroid Cancer
  • NTRK fusion assessment
  • Roma, Italy
    Regina Elena National Cancer Institute
Mar 31, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Carotid Intima-media Thickness in Patients Undergoing Thyroid

Recruiting
  • Plummer Disease
  • +6 more
  • Experimental
  • Milan, Italy
    Istituto Auxologico Italiano , IRCCS
Mar 7, 2023

Thyroid Cancer Trial in Hangzhou (Resection based on "thymus-vascular-inferior parathyroid" complex)

Not yet recruiting
  • Thyroid Cancer
  • Resection based on "thymus-vascular-inferior parathyroid" complex
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital Zhejiang University School of Medicin
Feb 24, 2023

Role of Endocrine Disruptors in Thyroid Cancer

Recruiting
  • Endocrine Disruptor Chemicals
  • Thyroid Cancer
  • Blood and urine diagnostic evaluation
  • Milan, Italy
    Istituto Auxologico Italiano, IRCCS
Feb 28, 2023

s and Clinical Variables on Thyroid Cancer

Recruiting
  • Thyroid Cancer
    • Milan, Italy
      Istituto Auxologico Italiano, IRCCS
    Mar 1, 2023